🇳🇵मानार्थ राजा

[Srinivas Mahesh Prasad Nephrologist @NephPrasad]

NEPHROLOGY NUMERICALS

#NEPHTWITTER

[Srinivas Mahesh Prasad Nephrologist @NephPrasad]

CAPD CALCULATION OF KT/V

#Nephtwitter

[Dr. AK 🇮🇳 @docakx]

2% of the people living in this area are fully resistant to HIV infection. They can never catch HIV.

Do you know the reason?

[CardiovascularCorner @TrackYourHeart]

ECG From Scratch #63: Pulmonary Embolism

Can an ECG diagnose pulmonary embolism (PE)?
Not reliably. But it can reveal clues to acute right ventricular overload.

Key findings:
🟨 Sinus tachycardia
🟦 S₁Q₃T₃ pattern
⬛ T-wave inversion in V₁–V₃
🟪 Right axis deviation
⬜ New RBBB
🟥 P pulmonale

⚠️ Remember: S₁Q₃T₃ is neither sensitive nor specific. A normal or nonspecific ECG does NOT exclude PE.

Always integrate ECG findings with clinical probability and appropriate imaging.

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

Timing and sequencing of Guideline-Directed Medical Therapy (GDMT) in CKD ca. 2026 from @asnpublications
#Nephpearls #KidneyWk

👉 https://t.co/s47TdzbMHq

[CardiovascularCorner @TrackYourHeart]

DILATED CARDIOMYOPATHY (DCM): A 12-PAGE VISUAL MASTERCLASS

What causes the heart to enlarge and lose its pumping function?

Explore DCM from diagnosis to management, including:
🔴 Causes & genetic forms
🔴 Echo, ECG & cardiac MRI findings
🔴 Guideline-directed treatment
🔴 Arrhythmias, ICD/CRT & complications
🔴 Reversible causes & prognosis

[Mystica Devkota @DevkotaMysti]

वाह! क्या गज्जब! यसमा मेरो पूर्ण समर्थन छ।

[NEJM @NEJM]

The discovery of 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 has advanced the prevention and treatment of gastritis, peptic ulcers, and gastric cancer. Progress has been made in the research of 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 infection. These advances are discussed in a new review.

Read the Review Article “𝘏𝘦𝘭𝘪𝘤𝘰𝘣𝘢𝘤𝘵𝘦𝘳 𝘱𝘺𝘭𝘰𝘳𝘪 Infection — Advances, Challenges, and the Road Ahead” by Hong Li, MD, PhD, Francis Megraud, MD, and Barry J. Marshall, MD: https://t.co/rMlsoi2ATy

[Alí S. Meza @AliSMV7]

🔺Dengue virus infection (Nature 2026)

https://t.co/g29GMe4YD6

[Jorge Faerron @cardiopedhnn]

#heart_failure_preserve_EF
2026 ACC Expert consensus.

https://t.co/eRXgrTFvRR

[Abdelhamed Hamdy @Abdelhamed012]

Retarding progression of CKD

[Abdelhamed Hamdy @Abdelhamed012]

KDIGO 2027 CKD Update: Drug Therapy in CKD

[Dr. AK 🇮🇳 @docakx]

20 common medicines and associated vitamin deficiencies

- Metformin – Vitamin B12 (sometimes folate)

- Furosemide (loop diuretics) – Thiamine (Vitamin B1)

- Oral contraceptives – Folate, Vitamin B6, Vitamin B12 (sometimes thiamine)

- Proton pump inhibitors (e.g., omeprazole, pantoprazole) – Vitamin B12

- H2-receptor antagonists (e.g., famotidine, ranitidine) – Vitamin B12

- Methotrexate – Folate (Vitamin B9)

- Isoniazid – Vitamin B6 (pyridoxine)

- Phenytoin – Folate, Vitamin D

- Carbamazepine – Folate, Vitamin D

- Phenobarbital – Vitamin D, Folate

- Cholestyramine – Vitamins A, D, E, K

- Orlistat – Vitamins A, D, E, K

- Trimethoprim (or trimethoprim-sulfamethoxazole) – Folate

- Corticosteroids (e.g., prednisone)

– Vitamin D, Vitamin C

- Broad-spectrum antibiotics (e.g., tetracyclines) – Vitamin K, B vitamins

- Hydralazine – Vitamin B6
- Levodopa – Vitamin B6
- Sulfasalazine – Folate
- Colchicine – Vitamin B12
- Rifampin – Vitamin D

This is general information drawn from established associations (e.g., Merck Manual listings and clinical sources). Deficiencies are not inevitable; monitoring and supplementation decisions depend on the individual patient, duration of use, diet, and other factors. Consult a physician for personalized advice.
(general associations; risk higher with long-term/high-dose use, not universal in all patients):

[KDIGO @goKDIGO]

The focused update of the KDIGO 2027 CKD Guideline is available for public review through November 4, 2026.

KDIGO invites the global kidney community to review the draft and share feedback to help inform and improve the final update.

Visit the KDIGO CKD Guideline website to download the draft and share your comments via the feedback survey:
https://t.co/WXDohGEU6A

The focused update addresses new evidence since publication of the KDIGO 2024 CKD Guideline on SGLT2 inhibitors, GLP-1-based therapies, and nsMRAs in people with CKD, excluding those receiving dialysis or who have received a kidney transplant.

Thank you for your time and insights.

[Jasmine Sethi @JasmineNephro]

🫘Approach to Renal Tubular Acidosis

@NDTsocial

https://t.co/WkwE8gs0hN

[AJKD @AJKDonline]

High Protein Diets: What to Tell Our Patients

https://t.co/eJKIYl0FWU

[Reels and Renal @ReelsR60609]

🩺 Dialysis Troubleshooting Series | Intradialytic Hypotension

Why does BP drop during hemodialysis?
Is it just excessive ultrafiltration, or is there more to it?
💡 Treat the mechanism, not just the BP!

Clinical question in the comments- Do reply ✌️

[Vincent Rajkumar @VincentRK]

Free Access: My 2026 update on diagnosis, risk stratification, treatment, and prognosis of multiple myeloma.

Link: https://t.co/VUheu7xTBZ @AjHematology

Algorithms. 10 Tables!
Bookmark!

[AJKD @AJKDonline]

Approach to Hematuria: Core Curriculum 2026

https://t.co/BKUurtiQcX (FREE)

@anna_zisman